Lessons Learned from FDA 483s on Poor SOP Revision Practices
Lessons Learned from FDA 483s on Poor SOP Revision Practices Key Takeaways from FDA 483s on Inadequate SOP Revision in Pharma When the USFDA inspects a pharmaceutical facility, Standard Operating Procedures (SOPs) are a central focus. Many FDA Form 483 observations directly cite deficiencies in SOP management—particularly regarding SOP revisions. Poor revision practices not only…
Read More “Lessons Learned from FDA 483s on Poor SOP Revision Practices” »